Sirukumab and adalimumab reduce power Doppler ultrasound signal in patients with rheumatoid arthritis by 4 weeks in a phase III trial.
作者信息
Sweet Kristen, Dasgupta Bidisha, de Vries Dick, Gourley Ian, Hsu Benjamin, Loza Matthew J, Taylor Peter C
机构信息
Janssen Research & Development, Spring House, Pennsylvania, USA.
Janssen Research & Development, Ambler, Pennsylvania, USA.
出版信息
Ann Rheum Dis. 2019 Oct;78(10):1439-1441. doi: 10.1136/annrheumdis-2019-215183. Epub 2019 Apr 24.
Abstract
摘要
Zotero 插件